chapter 4 infectious disease hybrid 2009
TRANSCRIPT
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 1/49
Infectious Diseases
Chapter 4
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 2/49
Infectious Diseases
When pathogenic microorganism find a
suitable environment for growth in the host.
MicroorganismsBacteria
Viruses
ParasitesFungi
Protoza
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 3/49
Parasitic Organisms
Round Worm Pin Worm
Hookworm
Tapeworm
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 4/49
Fungal Organisms
Epidermophyton floccosum
Candida albicans
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 5/49
Protozoa Organisms Giardia
Malaria
Trichomonas vaginalis
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 6/49
Viruses
HIV Virus
Influenza Virus
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 7/49
Bacteria Organisms
Bacillus anthracis
Staphlococcus or
Streptococcus
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 8/49
Transmission of Organisms
Direct Contact
Indirect Contact
Droplet Contact
Airborne Transmission
Fecal-oral Transmission Vector-borne Transmission
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 9/49
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 10/49
Emerging Infectious Diseases
Incidence of disease has increased within past 10 years Emerging Infectious Diseases
West Nile Virus Infection
SARS
Malaria Smallpox & Monkeypox
Anthrax
Hantavirus
Lyme Disease Escherichia coli O157:H7
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 11/49
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 12/49
West Nile Virus Encephalitis:
Etiology Virus that affects birds
Mosquito feeds on dead
birds
Virus enters mosquito’s
saliva
Mosquito bites human
Can cause Encephalitis
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 13/49
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 14/49
WNV: Diagnostic Tests
Blood tests looking for the virus(antigen)
and/or antibody in patients serum.
Antibody TestsAntibody Screen
ELISA Methodology
Antigen TestsPCR – polymerase chain reaction
Looks at DNA sequencing
NAT – nucleic acid testing
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 15/49
WNV: Treatment & Prevention
No known treatment Use analgesics & medications to relieve
symptoms
Alternative therapies
Prevention Use DEET mosquito repellant
Eliminate mosquito breeding sites
Install window & door screens
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 16/49
Malaria: Etiology Parasitic Infection
Transmitted via
mosquitoes
Parasites travel to liver & transform to
merozoites & ring forms
Merozoites enter RBCs
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 17/49
Malaria: Signs & Symptoms
Chills & fever
Headache & body aches
Nausea Vomiting
Diarrhea
Anemia
Jaundice
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 18/49
Malaria: Diagnostic Tests
Blood smear looking for the malariaparasites in red blood cells.
If found, must be reported to Health
Department for identification of species.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 19/49
Malaria: Treatment
Antimalaria drugs; varies with species
Blood donationsTraveled to endemic area – defer for 1-3
years
If had malaria –defer 3 years after full
recovery.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 20/49
Influenza
Acute infectious disease
Causitive Agent Infuenza A, B or C
Contracted by close person to person contact Respiratory droplets through coughing & sneezing
Touching infected objects & rubbing eyes, nose & mouth
Influenza virus infects the epithelial cells of therespiratory tract. Immunity Against
Interferon & the actions of cytotoxic T-cells.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 21/49
Influenza: Signs & Symptoms
Most severe in children & elderly Fever Myalgia & Headache
Dry cough; nasal discharge Croup Complications
PneumoniaEncephalopathyGuillian-Barre SyndromeReyes Syndrome
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 22/49
Influenza
Diagnostic & Prevention Diagnosis
Viral Culture – 3-5 days
Polymerase Chain Reaction (PCR) – 2 hours Detects viral RNA
Rapid Screening Test – 15 minutes
Prevention
Influenza Vaccination (Flu Shot)
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 23/49
Smallpox (Variola virus)
Serious, contagious, and sometimes fatalinfectious disease
No specific treatment Prevention is vaccination Virus has been eradiated except for
laboratory stockpiles Fear of bioterrorism
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 24/49
Monkey pox 1st outbreak in 2003 from handling prairie
dogs Rash→papule→vesicle that crusts over Fever, headache, malaise, backache,
lymphadenopathy Culture the virus or viral DNA antigen
testing Give antipyretics & analgesics
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 25/49
Hantavirus Pulmonary Syndrome
1st case in 1993 in SW US
Rodents shed virus in urine, dropping and salvia
which become aerosolized when walking & kicking
up ground Transmitted by breathing in aerosolized droplets
Flu-like symptoms; respiratory distress
Treat the symptoms High rate of mortality due to respiratory failure.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 26/49
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 27/49
Anthrax: Signs & Symptoms
Cutaneous anthrax raised itchy bump that develops into an ulcer
Inhalation anthrax fever, malaise, fatigue and sometimes a dry
cough; period of improvement followed by a crash -- trouble breathing,
sweating, bluish colored skin, shock death occurs 24-36 hours after the severe
symptoms begin
Gastrointestinal anthrax nausea, loss of appetite, vomiting, fever
followed by abdominal pain, vomiting of blood,and severe diarrhea.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 28/49
Inhalation Anthrax-Why so lethal?
Spores lay dormant in
powder
Germinate in lung tissue Multiplies to cause
infection
Toxins from bacteria
cause hemorrhaging &
tissue death
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 29/49
Anthrax: Diagnostic testing
Culture of the blood,
skin lesions, or
respiratory secretions
Measuring specific
antibodies in the blood
Biopsy for PCR &
Immunochemistry
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 30/49
Anthrax: Treatment
Cutaneous & Gastrointestinal - antibiotics
(amoxycillin, ciprofloxacin, erythromycin
and gentamycin) to treat skin andgastrointestinal infections.
Respiratory anthrax – Broad spectrum
antibiotics very hard to treat and nearly always fatal.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 31/49
Lyme Disease: Etiology
Tick-transmitted
spirochete – Borrelia
burgdorferi Very Small ticks
Seen more commonly
in northeast.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 32/49
Lyme Disease: Signs & Symptoms
Stage I – erythema chronicum
migrans (ECM) - bulls eye rash
Stage II – affects CNS ( meningitis, nervedamage and facial palsy
Stage III – chronic arthritis & continuingneurological problems
Fever, fatigue, chills, stiff neck, joint & musclepain
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 33/49
Lyme Disease: Diagnosis
Mainly done bysymptoms, especiallyEMC
Confirmation – takesweeks for antibody toappear, but bloodtests (ELISA & IFA)
Western Blot-lookingfor the viral antigen
Western Blot
Test looking for
DNA of organism
Simple Screening Test
looking for antibody
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 34/49
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 35/49
Escherichia Coli O157:H7
O157:H7 – one of many strains of
Escherichia coli bacteria.
O157:H7 – produces a harmful toxin Organisms found in cattle feces;
transmitted to humans through
contaminated meat Food born illness
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 36/49
E. Coli Infection: Signs & Symptoms
Abdominal cramps
Bloody stoolsHemolytic uremic syndrome (acute
kidney failure) O157:H7
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 37/49
E. Coli Infection: Diagnosis Treatment
Diagnosis: stool
cultures - growing the
organisms on an agar plate.
Treatment: Antibiotics
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 38/49
Multidrug-Resistant Organisms
Organisms resistant to antibiotics
MROsMRSA – methicilin/oxacillin-resistant
Staphylococcus aureus
VRE – vancomycin-resistant enterococci
PRSP – penicillin-resistant Streptococcus pneumoniae
ESBL – extended-spectrum beta-lactamase
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 39/49
Preventing Emerging Infectious
Diseases - CDC One of CDC’s goals/strategies for 21st
century – surveillance of infections.
Educating physicians & parents whyantibiotics should not be given for most
colds, coughs, sore throats, & runny
noses.
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 40/49
Immunosuppressant Syndromes
Chronic Fatigue
Syndrome
Acquired
Immunodeficiencysyndrome (AIDS)/
HIV Infection
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 41/49
Chronic Fatigue Syndrome Chronic debilitating fatigue
No known cause – associated with viral
infections.
Symptoms Fever & chills
Arthralgia
Sore Throat Lymphadenopathy
Sleep disturbance
Neurological – irritability, confusion, depression
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 42/49
Acquired Immunodeficiency
Syndrome (AIDS) Severe illness associated with HIV
HIV is a retrovirus that destroys T4
(helper) lymphocytes
Transmitted via blood & other body
fluids
First case diagnosed in 1981
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 43/49
AIDS STATISTICS
SEX
AGE
Transmission
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 44/49
AIDS’ Signs & Symptoms Fever & flulike symptoms
Pulmonary Infections: Pneumocystis jiroveci
Shortness of breath, dyspnea, coughing, chest pain
Gastrointestinal symptoms: Loss of appetite, nausea, vomiting, oral and esophagel
candidiasis, chronic diarrhea
Neurological symptoms
Memory loss, headache, depression, confusion
Malignancies
Kaposi’s sarcoma,
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 45/49
AIDS’ Diagnosis
ELISA Antibody Test Tests detects antibody
produced to HIV
If positive, must be
confirmed using Western
Blot Test
Viral Load TestWestern Blot Test
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 46/49
AIDS’ Treatment Nucleoside Reverse Transcriptase Inhibitors – to
reduce the HIV in body Abacavir (Ziagen, ABC) Didanosine (Videx, dideoxyinosine, ddI)
Emtricitabine (Emtriva, FTC) Lamivudine (Epivir, 3TC) Stavudine (Zerit, d4T) Tenofovir (Viread, TDF) Zalcitabine (Hivid, ddC) Zidovudine (Retrovir, ZDV or AZT)
Alternative treatments to keep immune systemhealthy
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 47/49
Childhood Communicable Diseases
Rubeola (Measles) Rubella (German Measles)
Erythema Infectiosum (Fifth Disease) Mumps Varicella (Chickenpox) Diphtheria Pertussis (Whooping Cough) Tetanus (Lockjaw)
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 48/49
8/14/2019 Chapter 4 Infectious Disease Hybrid 2009
http://slidepdf.com/reader/full/chapter-4-infectious-disease-hybrid-2009 49/49
Immunization Protection against communicable diseases